Growth Metrics

Fresenius Medical Care AG (FMS) Income towards Parent Company: 2009-2024

Historic Income towards Parent Company for Fresenius Medical Care AG (FMS) over the last 16 years, with Dec 2024 value amounting to $574.8 million.

  • Fresenius Medical Care AG's Income towards Parent Company rose 25.59% to -$739.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$739.2 million, marking a year-over-year increase of 25.59%. This contributed to the annual value of $574.8 million for FY2024, which is 6.49% up from last year.
  • Per Fresenius Medical Care AG's latest filing, its Income towards Parent Company stood at $574.8 million for FY2024, which was up 6.49% from $539.8 million recorded in FY2023.
  • Over the past 5 years, Fresenius Medical Care AG's Income towards Parent Company peaked at $1.3 billion during FY2020, and registered a low of $539.8 million during FY2023.
  • Moreover, its 3-year median value for Income towards Parent Company was $574.8 million (2024), whereas its average is $608.1 million.
  • In the last 5 years, Fresenius Medical Care AG's Income towards Parent Company plummeted by 38.13% in 2022 and then increased by 6.49% in 2024.
  • MRY analysis of 5 years shows Fresenius Medical Care AG's Income towards Parent Company stood at $1.3 billion in 2020, then fell by 13.72% to $1.1 billion in 2021, then crashed by 38.13% to $709.7 million in 2022, then dropped by 23.95% to $539.8 million in 2023, then increased by 6.49% to $574.8 million in 2024.
  • Its Income towards Parent Company stands at $574.8 million for FY2024, versus $539.8 million for FY2023 and $709.7 million for FY2022.